Ultrasound-derived visceral adipose tissue as a reliable marker of hepato-metabolic risk in patients with MASLD
Digestive and Liver Disease · 2026
DOI: 10.1016/j.dld.2025.11.008 ↗Kurz gefasst
Fachartikel in der Zeitschrift Digestive and Liver Disease, 2026. Verfasst von Valentina Flagiello und 12 weiteren Autor:innen. Beteiligte Einrichtung: Operative Research Unit of Clinical Medicine and Hepatology, Fondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo, 200 - 0…. Hauptthemen laut MEDLINE: Intra-Abdominal Fat, Fatty Liver. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
There is increasing evidence that visceral adipose tissue (VAT) plays a key role in the pathogenesis of metabolic dysfunction-associated steatotic liver disease (MASLD), yet its clinical assessment remains limited by the need for advanced imaging. In this cross-sectional study of 747 patients at metabolic risk, we evaluated whether ultrasound (US)-measured VAT is more strongly associated with hepatic steatosis and metabolic dysfunction than conventional anthropometric indices. Hepatic fat was quantified via ultrasound-derived fat fraction (UDFF), while liver stiffness and FibroScan-AST (FAST) score assessed disease severity. Stratification by VAT tertiles showed a progressive increase in UDFF and the prevalence of diabetes, hypertension, and dyslipidaemia. VAT correlated more strongly than body mass index (BMI) and waist circumference (WC) with triglycerides and UDFF (p < 0.05), and was more strongly associated with HbA1c, ALT and FAST than BMI. In standardized multivariate analysis, VAT remained independently associated with UDFF (beta= 2.49, p < 0.001). Associations of VAT with UDFF and metabolic parameters were stronger in women than in men. These findings support the use of US-derived VAT as a non-invasive and low-cost biomarker to improve risk stratification beyond BMI and WC, serving as a practical tool to monitor response to therapies targeting visceral fat, in MASLD management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Operative Research Unit of Clinical Medicine and Hepatology, Fondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo, 200 - 00128 Roma, Italy.
- Operative Research Unit of Clinical Medicine and Hepatology, Fondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo, 200 - 00128 Roma, Italy. Electronic address: paolo.gallo@policlinicocampus.it.
- Internal Medicine Unit, Fondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo, 21, 00128 Roma, Italy; Research Unit of Internal Medicine, Department of Medicine and Surgery, Università Campus B…
- MASLD Research Center, Division of Gastroenterology and Hepatology, University of California at San Diego, La Jolla, CA, United States.
- Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.
- Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.
Zitieren
APA
Flagiello, V., Gallo, P., Terracciani, F., Falcomatà, A., De Vincentis, A., Pasquale, G. D., Avagliano, J., Tavaglione, F., Sparapano, S., Daniels, S. J., Blau, J. E., Picardi, A., & Vespasiani-Gentilucci, U. (2026). Ultrasound-derived visceral adipose tissue as a reliable marker of hepato-metabolic risk in patients with MASLD. Digestive and Liver Disease. https://doi.org/10.1016/j.dld.2025.11.008
Vancouver
Flagiello V, Gallo P, Terracciani F, Falcomatà A, De Vincentis A, Pasquale GD, et al. Ultrasound-derived visceral adipose tissue as a reliable marker of hepato-metabolic risk in patients with MASLD. Digestive and Liver Disease. 2026. doi:10.1016/j.dld.2025.11.008
BibTeX
@article{Flagiello2026,
author = {Flagiello, Valentina and Gallo, Paolo and Terracciani, Francesca and Falcomatà, Andrea and De Vincentis, Antonio and Pasquale, Giulia Di and Avagliano, Jessica and Tavaglione, Federica and Sparapano, Silvia and Daniels, Samuel J and Blau, Jenny E and Picardi, Antonio and Vespasiani-Gentilucci, Umberto},
title = {Ultrasound-derived visceral adipose tissue as a reliable marker of hepato-metabolic risk in patients with MASLD},
journal = {Digestive and Liver Disease},
year = {2026},
doi = {10.1016/j.dld.2025.11.008}
}
EUVIMED